Exelon (NASDAQ:EXC) Price Target Raised to $50.00

Exelon (NASDAQ:EXC) had its price target upped by stock analysts at BMO Capital Markets from $46.00 to $50.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ target price suggests a potential upside of 7.40% from the stock’s previous close.

EXC has been the topic of a number of other research reports. UBS Group increased their price target on shares of Exelon from $45.00 to $47.00 and gave the stock a “neutral” rating in a report on Friday, March 21st. Guggenheim set a $47.00 price target on Exelon and gave the company a “buy” rating in a research report on Tuesday, April 22nd. Barclays lifted their price target on Exelon from $42.00 to $48.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 25th. Scotiabank increased their price objective on Exelon from $42.00 to $44.00 and gave the company a “sector perform” rating in a research report on Thursday, February 13th. Finally, Morgan Stanley boosted their target price on Exelon from $46.00 to $48.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 20th. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $46.67.

Exelon Price Performance

NASDAQ:EXC traded up $0.34 during mid-day trading on Monday, hitting $46.56. 1,020,882 shares of the stock traded hands, compared to its average volume of 7,248,083. The business’s 50-day moving average price is $44.73 and its 200 day moving average price is $41.05. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61. The company has a market cap of $47.00 billion, a PE ratio of 18.97, a price-to-earnings-growth ratio of 2.86 and a beta of 0.39. Exelon has a 12-month low of $34.01 and a 12-month high of $48.11.

Exelon (NASDAQ:EXC) last posted its earnings results on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.59 by $0.05. Exelon had a return on equity of 9.52% and a net margin of 10.68%. During the same quarter in the previous year, the business earned $0.60 earnings per share. On average, analysts expect that Exelon will post 2.64 EPS for the current fiscal year.

Insider Activity at Exelon

In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the firm’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $40.57, for a total value of $59,353.91. Following the completion of the sale, the executive vice president now directly owns 2,271 shares in the company, valued at $92,134.47. This trade represents a 39.18 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.10% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Exelon

Institutional investors have recently added to or reduced their stakes in the company. Norges Bank purchased a new position in Exelon during the 4th quarter valued at about $479,597,000. Price T Rowe Associates Inc. MD increased its stake in shares of Exelon by 37.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company’s stock valued at $1,039,545,000 after purchasing an additional 7,483,873 shares in the last quarter. FMR LLC lifted its holdings in shares of Exelon by 46.9% during the fourth quarter. FMR LLC now owns 17,306,652 shares of the company’s stock valued at $651,422,000 after purchasing an additional 5,524,103 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Exelon by 43.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,846,030 shares of the company’s stock worth $483,525,000 after purchasing an additional 3,878,687 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Exelon by 109.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock worth $238,608,000 after buying an additional 3,068,309 shares during the last quarter. Institutional investors own 80.92% of the company’s stock.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.